tirzepatide clinical trials near me New trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Tirzepatide Specialist Near Me in

Ro recently published the first study to evaluate both the long-term weight loss and safety outcomes of treatment with semaglutide via telehealth

While vitamin B12 has the power to lower the risk of heart disease, it is also linked to the fact that individuals with healthy levels of Vitamin B12 are more likely to spend time outdoors and exercise

If your main focus is gut health, oral BPC 157 may offer benefits directly in the digestive system

Lu SC, Chen M, Atangan L, Killion EA, Komorowski R, Cheng Y, et al

Metformin has decades of data on modest weight neutrality and possible cardiovascular protection

The WL was primarily due to reductions in fat mass with less impact on lean mass